Cargando…
Anti‐PrP monoclonal antibody as a novel treatment for neurogenesis in mouse model of Alzheimer's disease
BACKGROUND: Alzheimer's disease (AD) is the most common degenerative disease characterized by cognitive impairment, memory decline, and language disorder for which there is no effective treatment. Neurogenesis has been indicated in AD and may play an important role in the pathogenesis of AD. Ta...
Autores principales: | Li, Ruolin, Ren, Ming, Yu, Yingxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613428/ https://www.ncbi.nlm.nih.gov/pubmed/34672433 http://dx.doi.org/10.1002/brb3.2365 |
Ejemplares similares
-
Anti-PrP(C )monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer's disease model mouse
por: Chung, Erika, et al.
Publicado: (2010) -
Passive Immunization With a Novel Monoclonal Anti-PrP Antibody TW1 in an Alzheimer’s Mouse Model With Tau Pathology
por: Boutajangout, Allal, et al.
Publicado: (2021) -
Enhancement of binding avidity by bivalent binding enables PrP(Sc)-specific detection by anti-PrP monoclonal antibody 132
por: Suzuki, Akio, et al.
Publicado: (2019) -
Treatment of microglia with Anti-PrP monoclonal antibodies induces neuronal apoptosis in vitro
por: Adhikari, Utpal Kumar, et al.
Publicado: (2021) -
Heterogeneity of Abnormal Prion Protein (PrP(Sc)) in Murine Scrapie
Prions Determined by PrP(Sc)-Specific Monoclonal Antibodies
por: USHIKI-KAKU, Yuko, et al.
Publicado: (2013)